Thema: AU000000MSB8
MESO, AU000000MSB8
stock-6690192_1920.jpg - Foto: THN
Mesoblast stock gains attention as Ryoncil revenue rises 44 percent
Mesoblast stock is in focus after Ryoncil revenue rose 44 percent in the first quarter. Cash spending fell sharply as late-stage trials advanced.
ad-hoc-news.de, heute 18:48 Uhr
MESO, AU000000MSB8
Bell Potter keeps AUD 4.40 target for Mesoblast stock after ...
Ryoncil sales reached USD 28.00 million against a USD 40.00 million forecast. Mesoblast stock costs EUR 1.18 on October 27, 2026.
ad-hoc-news.de, 27.10.26 18:56 Uhr
MESO, AU000000MSB8
Mesoblast reports 44 percent Ryoncil growth. Mesoblast stock ...
Bell Potter trims its target to AUD 4.40 on October 16, 2026. Mesoblast stock costs EUR 1.12 on October 24, 2026, down 3.11 percent versus Tradegate.
ad-hoc-news.de, 24.10.26 18:55 Uhr
MESO, AU000000MSB8
Mesoblast stock: Consensus cuts 2027 revenue forecast for ...
Consensus lifts 2027 loss forecast to USD 0.017 per share. Mesoblast stock costs EUR 1.14 on October 22, 2026 at Lang & Schwarz.
ad-hoc-news.de, 22.10.26 20:49 Uhr
MESO, AU000000MSB8
Bell Potter sets AUD 4.40 target for Mesoblast stock
Ryoncil sales were USD 28.00 million versus a USD 40.00 million forecast. Mesoblast stock costs EUR 1.12 on October 20, 2026.
ad-hoc-news.de, 20.10.26 18:35 Uhr
MESO, AU000000MSB8
Mesoblast schedules November 10 meeting while Mesoblast ...
Target fell to AUD 3.64 on September 15, 2026. Mesoblast stock was last at EUR 1.19 on October 16, 2026, down 2.10 percent versus Tradegate close.
ad-hoc-news.de, 17.10.26 20:32 Uhr
MESO, AU000000MSB8
Three analysts set AUD 3.64 target for Mesoblast stock 82.91 ...
Mesoblast stock sits 39.88 percent below its AUD 3.31 high. It costs EUR 1.23 on October 15, 2026 at 9:05 p.m. CEST in after-hours trading.
ad-hoc-news.de, 15.10.26 21:12 Uhr
MESO, AU000000MSB8
Mesoblast stock reports fiscal revenue of USD 120.3 million ...
Mesoblast stock carries a Hold consensus from 3 analysts. Fiscal 2026 net loss narrowed to USD 57.5 million from USD 102.1 million.
ad-hoc-news.de, 08.10.26 08:55 Uhr
MESO, AU000000MSB8
Mesoblast wins FDA assay approval: what it means for Mesoblast ...
For Mesoblast stock, TIBA will monitor every new Ryoncil lot. Fiscal 2026 revenue reached USD 120.25 million, up 599.20 percent.
ad-hoc-news.de, 07.10.26 00:18 Uhr
